Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling

The differential expression of the critical cell cycle control proteins cyclin D1 and c-myc has been shown to result in Akt-dependent hypersensitivity of tumor cells to mTOR inhibitors. We have previously demonstrated that the differential utilization of internal ribosome entry sites within the mRNAs of these transcripts allows maintenance of protein synthesis in the face of rapamycin (rapa) exposure in an Akt-dependent manner. Here, we demonstrate that in addition to this mechanism, cyclin D1 and c-myc mRNA stability is also coordinately regulated following rapa treatment depending on Akt activity status. We identify A/U-rich response elements within the 3′ untranslated regions (UTRs) of these transcripts, which confer the observed differential stabilities and show that the RNA-binding protein, tristetraprolin (TTP), interacts with these elements. We also present evidence that TTP accumulates in response to rapa exposure, binds to the cis-acting elements within the cyclin D1 and c-myc 3′ UTRs and is differentially serine phosphorylated in an Akt-dependent manner. Furthermore, the differential phosphorylation status of TTP results in its sequestration by 14-3-3 proteins in quiescent Akt-containing cells. Finally, siRNA-mediated knockdown of TTP expression or inhibiting a known regulator of TTP phosphorylation, p38 MAP kinase, abolishes the effects on cyclin D1 and c-myc mRNA stability. We assume that the differential control of cyclin D1 and c-myc mRNA stability and translational efficiency constitutes a coordinate response to rapa contributing to the maintenance of expression of these determinants in rapa-resistant quiescent Akt-containing cells following exposure.

[1]  Joseph Gera,et al.  Cyclin D1 and c-myc Internal Ribosome Entry Site (IRES)-dependent Translation Is Regulated by AKT Activity and Enhanced by Rapamycin through a p38 MAPK- and ERK-dependent Pathway* , 2005, Journal of Biological Chemistry.

[2]  Shile Huang,et al.  mTOR as a target for cancer therapy. , 2004, Current topics in microbiology and immunology.

[3]  P. Anderson,et al.  Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. , 2002, Biochemical Society transactions.

[4]  J. Dean,et al.  The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. , 2004, Cellular signalling.

[5]  M. Gorospe,et al.  AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1: involvement in the nuclear import of RNA-binding protein HuR. , 2004, The Journal of biological chemistry.

[6]  J. Blenis,et al.  An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Blackshear.  Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. , 2001, Biochemical Society transactions.

[8]  J. Connolly,et al.  Analysis of the function, expression, and subcellular distribution of human tristetraprolin. , 2002, Arthritis and rheumatism.

[9]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[10]  P. Anderson,et al.  MK2‐induced tristetraprolin:14‐3‐3 complexes prevent stress granule association and ARE‐mRNA decay , 2004, The EMBO journal.

[11]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[12]  B. Hemmings,et al.  The ARE‐dependent mRNA‐destabilizing activity of BRF1 is regulated by protein kinase B , 2004, The EMBO journal.

[13]  M. Hung,et al.  Regulation of the Activity of p38 Mitogen-Activated Protein Kinase by Akt in Cancer and Adenoviral Protein E1A-Mediated Sensitization to Apoptosis , 2003, Molecular and Cellular Biology.

[14]  Elmar Wahle,et al.  Messenger RNA Turnover in Eukaryotes: Pathways and Enzymes , 2004, Critical reviews in biochemistry and molecular biology.

[15]  I. Mellinghoff,et al.  AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression* , 2004, Journal of Biological Chemistry.

[16]  S. Peltz,et al.  Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.

[17]  J. Dean,et al.  p38 Mitogen-activated Protein Kinase Stabilizes mRNAs That Contain Cyclooxygenase-2 and Tumor Necrosis Factor AU-rich Elements by Inhibiting Deadenylation* , 2003, Journal of Biological Chemistry.

[18]  N. Sonenberg,et al.  The mRNA closed-loop model: the function of PABP and PABP-interacting proteins in mRNA translation. , 2001, Cold Spring Harbor symposia on quantitative biology.

[19]  A. Shyu,et al.  RNA stabilization by the AU‐rich element binding protein, HuR, an ELAV protein , 1998, The EMBO journal.

[20]  N. Sonenberg,et al.  Regulation of cap-dependent translation by eIF4E inhibitory proteins , 2005, Nature.

[21]  R. Abraham.  TOR Signaling: An Odyssey from Cellular Stress to the Cell Growth Machinery , 2005, Current Biology.

[22]  David M Sabatini,et al.  An expanding role for mTOR in cancer. , 2005, Trends in molecular medicine.

[23]  Marco Colombi,et al.  Functional cloning of BRF1, a regulator of ARE‐dependent mRNA turnover , 2002, The EMBO journal.

[24]  P. Nelson,et al.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.

[25]  Hong Wu,et al.  Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis , 2002, Molecular and Cellular Biology.

[26]  P. Bernstein,et al.  Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. , 1992, Genes & Development.

[27]  G. M. Wilson,et al.  Down-Regulation of Cyclin D1 Expression by Prostaglandin A2 Is Mediated by Enhanced Cyclin D1 mRNA Turnover , 2000, Molecular and Cellular Biology.

[28]  J. Shabanowitz,et al.  MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 Binding* , 2004, Journal of Biological Chemistry.

[29]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[30]  K. Mahtani,et al.  Mitogen-Activated Protein Kinase p38 Controls the Expression and Posttranslational Modification of Tristetraprolin, a Regulator of Tumor Necrosis Factor Alpha mRNA Stability , 2001, Molecular and Cellular Biology.

[31]  D. Morrison,et al.  Unlocking the code of 14-3-3 , 2004, Journal of Cell Science.

[32]  Shuang Huang,et al.  Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes Urokinase Plasminogen Activator mRNA Stability in Invasive Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[33]  P. Blackshear,et al.  Influence of Nonameric AU-rich Tristetraprolin-binding Sites on mRNA Deadenylation and Turnover* , 2005, Journal of Biological Chemistry.

[34]  Hong Wu,et al.  Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Sessa,et al.  Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[36]  T. Golub,et al.  The Immunosuppressant Rapamycin Mimics a Starvation-Like Signal Distinct from Amino Acid and Glucose Deprivation , 2002, Molecular and Cellular Biology.

[37]  C. Y. Chen,et al.  AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.

[38]  A. Jaeschke,et al.  Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.

[39]  D. Sabatini,et al.  Raptor and mTOR: subunits of a nutrient-sensitive complex. , 2004, Current topics in microbiology and immunology.

[40]  J. Connolly,et al.  The Role of mRNA Turnover in the Regulation of Tristetraprolin Expression: Evidence for an Extracellular Signal-Regulated Kinase-Specific, AU-Rich Element-Dependent, Autoregulatory Pathway1 , 2004, The Journal of Immunology.

[41]  C. Demaria,et al.  AUF1 Binding Affinity to A+U-rich Elements Correlates with Rapid mRNA Degradation (*) , 1996, The Journal of Biological Chemistry.

[42]  Myriam Gorospe,et al.  HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation , 2000, The EMBO journal.

[43]  Shuang Huang,et al.  Involvement of MicroRNA in AU-Rich Element-Mediated mRNA Instability , 2005, Cell.

[44]  H. Hermeking.  The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.

[45]  J. Wilusz,et al.  Bringing the role of mRNA decay in the control of gene expression into focus. , 2004, Trends in genetics : TIG.

[46]  P. Houghton,et al.  Therapeutic potential of target of rapamycin inhibitors , 2004, Expert opinion on therapeutic targets.

[47]  G. M. Wilson,et al.  Regulation of A + U-rich Element-directed mRNA Turnover Involving Reversible Phosphorylation of AUF1* , 2003, Journal of Biological Chemistry.

[48]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[49]  I. Lemm,et al.  Regulation of c-myc mRNA Decay by Translational Pausing in a Coding Region Instability Determinant , 2002, Molecular and Cellular Biology.